{"prompt": "['PREDM', 'Page 49', '12.3 Stopping Rules', 'This ad hoc stopping rule is designed based on unacceptable toxicity of metformin. A', 'rate of discontinuation of metformin > -10% would be considered unacceptable. If', 'among first 20 survivors more than 5, and among 41 survivors, more than 8 of them', 'discontinue (stop taking for 7 or more days without intent to resume) metformin due to', 'toxicity, then the trial will be stopped. These stopping rules are based on the exact 95%', 'lower confidence bounds for the probability of failure.', '13.0 OBTAINING INFORMED CONSENT', '13.1 Informed Consent Prior to Research Interventions', 'Informed consent will be obtained prior to all study related observations,', 'evaluations and interventions.', '13.2 Consent at Age of Majority', 'N/A; Participants must be 18 years or older to enroll on the study.', '13.3 Consent When English is Not the Primary Language', 'Due to current limitations of the digital lifestyle change platform, participants who', 'are unable to participate in English will not be eligible for this study.', 'Initial version, dated: 04-10-20', 'IRB approkB', \"St. Jude date Children's Research Hospital\", 'NUMBER: 20-0550', 'Protocol document date: 10-12-2020', 'IRB APPROVAL DATE: 11/10/2020']['PREDM', 'Page 50', 'REFERENCES', '1.', 'Maddux BA, Chan A, Mandarino LJ, et al: IGF-Binding Protein-1 levels are', 'related to insulin-mediated glucose disposal and are a potential serum marker of insulin', 'resistance. Diabetes Care 29:1535-1537, 2006', '2.', 'Meacham LR, Sklar CA, LiS, et al: Diabetes mellitus in long-term survivors of', 'childhood cancer. Increased risk associated with radiation therapy: a report for the', 'childhood cancer survivor study. Arch Intern Med 169:1381-8, 2009', '3.', 'Mostoufi-Moab S, Seidel K, Leisenring WM, et al: Endocrine Abnormalities in', 'Aging Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor', 'Study. J Clin Oncol 34:3240-7, 2016', '4.', 'Armstrong GT, Chen Y, Yasui Y, et al: Reduction in late mortality among 5-year', 'survivors of childhood cancer. N Engl J Med 374:833-42, 2016', '5.', 'Armstrong GT, Oeffinger KC, Chen Y, et al: Modifiable risk factors and major', 'cardiac events among adult survivors of childhood cancer. J Clin Oncol 31:3673-80, 2013', '6.', 'Low Wang CC, Hess CN, Hiatt WR, et al: Clinical Update: Cardiovascular', 'Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in', 'Type 2 Diabetes Mellitus - Mechanisms, Management, and Clinical Considerations.', 'Circulation 133:2459-2502, 2016', '7.', 'Stratton IM, Adler AI, Neil HA, et al: Association of glycaemia with', 'macrovascular and microvascular complications of type 2 diabetes (UKPDS 35):', 'prospective observational study. BMJ (Clinical research ed.) 321:405-412, 2000', '8.', 'Gregg EW, Cheng YJ, Srinivasan M, et al: Trends in cause-specific mortality', 'among adults with and without diagnosed diabetes in the USA: an epidemiological analysis', 'of linked national survey and vital statistics data. Lancet 391:2430-2440, 2018', '9.', 'Knowler WC, Fowler SE, Hamman RF, et al: 10-year follow-up of diabetes', 'incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet', '374:1677-86, 2009', '10.', 'Morris DH, Khunti K, Achana F, et al: Progression rates from HbA1c 6.0-6.4%', 'and other prediabetes definitions to type 2 diabetes: a meta-analysis. Diabetologia 56:1489-', '1493, 2013', '11.', 'Rena G, Hardie DG, Pearson ER: The mechanisms of action of metformin.', 'Diabetologia 60:1577-1585, 2017', '12.', 'Knowler WC, Barrett-Connor E, Fowler SE, et al: Reduction in the incidence of', 'type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403, 2002', '13.', 'The Diabetes Prevention Program. Design and methods for a clinical trial in the', 'prevention of type 2 diabetes. Diabetes Care 22:623-34, 1999', '14.', 'Tseng E, Yeh HC, Maruthur NM: Metformin Use in Prediabetes Among U.S.', 'Adults, 2005-2012. Diabetes Care 40:887-893, 2017', '15.', 'Menke A, Casagrande S, Geiss L, et al: Prevalence of and Trends in Diabetes', 'Among Adults in the United States, 1988-2012. Jama 314:1021-9, 2015', '16.', 'The Diabetes Prevention Program (DPP): description of lifestyle intervention.', 'Diabetes Care 25:2165-71, 2002', '17.', 'Flory J, Lipska K: Metformin in 2019: use of metformin for type 2 diabetes in', '2019. JAMA 321:1926-1927, 2019', '18.', 'Bonnet F, Scheen A: Understanding and overcoming metformin gastrointestinal', 'intolerance. Diabetes Obes Metab 19:473-481, 2017', \"St. Jude Children's Research Hospital\", 'Initial version, dated: 04-10-20', 'IRB approkB date 00-00-00', 'NUMBER: 20-0550', 'Protocol document date: 10-12-2020', 'IRB APPROVAL DATE: 11/10/2020']\n\n###\n\n", "completion": "END"}